27th Dec 2006 14:53
Immupharma PLC27 December 2006 ImmuPharma PLC (the "Company") Voting Rights and Capital 27 December 2006 In conformity with the Transparency Directive's transitional provision 6, theCompany notifies the market of the following: The Company's issued share capital consists of 72,488,149 Ordinary Shares of 10peach which entitle the holder to one vote per share. Therefore, the total number of voting rights is 72,488,149. The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in, the Company under the FSA'sDisclosure and Transparency Rules. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Immupharma